Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy
- PMID: 28567503
- DOI: 10.1007/s00066-017-1151-8
Planning benchmark study for SBRT of early stage NSCLC : Results of the DEGRO Working Group Stereotactic Radiotherapy
Abstract
Purpose: The aim was to evaluate stereotactic body radiation therapy (SBRT) treatment planning variability for early stage nonsmall cell lung cancer (NSCLC) with respect to the published guidelines of the Stereotactic Radiotherapy Working Group of the German Society for Radiation Oncology (DEGRO).
Materials and methods: Planning computed tomography (CT) scan and the structure sets (planning target volume, PTV; organs at risk, OARs) of 3 patients with early stage NSCLC were sent to 22 radiotherapy departments with SBRT experience: each department was asked to prepare a treatment plan according to the DEGRO guidelines. The prescription dose was 3 fractions of 15 Gy to the 65% isodose.
Results: In all, 87 plans were generated: 36 used intensity-modulated arc therapy (IMAT), 21 used three-dimensional conformal radiation therapy (3DCRT), 6 used static field intensity-modulated radiation therapy (SF-IMRT), 9 used helical radiotherapy and 15 used robotic radiosurgery. PTV dose coverage and simultaneously kept OARs doses were within the clinical limits published in the DEGRO guidelines. However, mean PTV dose (mean 58.0 Gy, range 52.8-66.4 Gy) and dose conformity indices (mean 0.75, range 0.60-1.00) varied between institutions and techniques (p ≤ 0.02). OARs doses varied substantially between institutions, but appeared to be technique independent (p = 0.21).
Conclusion: All studied treatment techniques are well suited for SBRT of early stage NSCLC according to the DEGRO guidelines. Homogenization of SBRT practice in Germany is possible through the guidelines; however, detailed treatment plan characteristics varied between techniques and institutions and further homogenization is warranted in future studies and recommendations. Optimized treatment planning should always follow the ALARA (as low as reasonably achievable) principle.
Keywords: Nonsmall cell lung cancer; Organs at risk; Planning benchmark study; Quality assurance; Stereotactic radiation therapy.
Comment in
-
Time for crowd knowledge-based approach in SBRT planning.Strahlenther Onkol. 2017 Dec;193(12):1066-1067. doi: 10.1007/s00066-017-1214-x. Epub 2017 Sep 13. Strahlenther Onkol. 2017. PMID: 28905198 English. No abstract available.
-
Time for standardization of SBRT planning through large scale clinical data and guideline-based approaches.Strahlenther Onkol. 2017 Dec;193(12):1068-1069. doi: 10.1007/s00066-017-1216-8. Epub 2017 Sep 15. Strahlenther Onkol. 2017. PMID: 28916902 English. No abstract available.
Similar articles
-
Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.J Appl Clin Med Phys. 2016 May 8;17(3):277-293. doi: 10.1120/jacmp.v17i3.6077. J Appl Clin Med Phys. 2016. PMID: 27167284 Free PMC article.
-
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose.Strahlenther Onkol. 2021 Sep;197(9):836-846. doi: 10.1007/s00066-021-01799-w. Epub 2021 Jul 1. Strahlenther Onkol. 2021. PMID: 34196725 Free PMC article.
-
Evaluation of plan quality and treatment efficiency for single-isocenter/two-lesion lung stereotactic body radiation therapy.J Appl Clin Med Phys. 2019 Jan;20(1):118-127. doi: 10.1002/acm2.12500. Epub 2018 Dec 8. J Appl Clin Med Phys. 2019. PMID: 30548205 Free PMC article.
-
[Stereotactic Body Radiotherapy for Early Stage NSCLC - What Is the Evidence?].Zentralbl Chir. 2017 Sep;142(S 01):S17-S25. doi: 10.1055/s-0043-117177. Epub 2017 Sep 28. Zentralbl Chir. 2017. PMID: 28958106 Review. German.
-
Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):160-171. doi: 10.1016/j.ijrobp.2019.03.045. Epub 2019 Apr 5. Int J Radiat Oncol Biol Phys. 2021. PMID: 30954520 Free PMC article. Review.
Cited by
-
SBRT planning for spinal metastasis: indications from a large multicentric study.Strahlenther Onkol. 2019 Mar;195(3):226-235. doi: 10.1007/s00066-018-1383-2. Epub 2018 Oct 23. Strahlenther Onkol. 2019. PMID: 30353349 English.
-
Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer.Lung Cancer (Auckl). 2019 Dec 20;10:151-159. doi: 10.2147/LCTT.S235713. eCollection 2019. Lung Cancer (Auckl). 2019. PMID: 31908556 Free PMC article.
-
Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.Thorac Cancer. 2019 Feb;10(2):321-329. doi: 10.1111/1759-7714.12966. Epub 2019 Jan 7. Thorac Cancer. 2019. PMID: 30618120 Free PMC article. Clinical Trial.
-
Direct dose correlation of MRI morphologic alterations of healthy liver tissue after robotic liver SBRT.Strahlenther Onkol. 2018 May;194(5):414-424. doi: 10.1007/s00066-018-1271-9. Epub 2018 Feb 5. Strahlenther Onkol. 2018. PMID: 29404626 English.
-
The role of EPID in vivo dosimetry in the risk management of stereotactic lung treatments.Strahlenther Onkol. 2023 Nov;199(11):992-999. doi: 10.1007/s00066-023-02081-x. Epub 2023 May 31. Strahlenther Onkol. 2023. PMID: 37256302
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical